ストックスクリーナーアプリを入手
0.44
22.22%
0.08
前日終値:
$0.36
開ける：
$0.4022
24時間の取引高:
26,647
Relative Volume:
0.28
時価総額：
$17.95M
収益：
-
当期純損益:
$-7.98M
株価収益率:
-2.2657
EPS:
-0.1942
ネットキャッシュフロー:
$-5.84M
1週間 パフォーマンス:
+2.06%
1か月 パフォーマンス:
-46.42%
6か月 パフォーマンス:
-81.51%
1年 パフォーマンス:
-57.28%
1日の値動き範囲:
$0.40
$0.45
1週間の範囲:
$0.3502
$0.5436
52週間の値動き範囲:
$0.3502
$3.39
Anebulo Pharmaceuticals Inc Stock (ANEB) Company Profile
名前
Anebulo Pharmaceuticals Inc
セクター
電話
737 203 5270
住所
C/O ANEBULO PHARMACEUTICALS, INC., LAKEWAY
Compare ANEB vs VRTX, REGN, ARGX, ALNY, ONC
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ANEB
Anebulo Pharmaceuticals Inc
|
0.44 | 14.68M | 0 | -7.98M | -5.84M | -0.1942 |
|
VRTX
Vertex Pharmaceuticals Inc
|
460.82 | 121.40B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
764.93 | 83.25B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
728.11 | 46.39B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
320.51 | 43.41B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
292.94 | 33.09B | 5.36B | 287.73M | 924.18M | 2.5229 |
Anebulo Pharmaceuticals Inc (ANEB) 最新ニュース
Diluted shares outstanding of Anebulo Pharmaceuticals Inc – OTC:ANEB - TradingView
Update Recap: What are Anebulo Pharmaceuticals Incs earnings expectationsEarnings Miss & High Conviction Buy Zone Picks - baoquankhu1.vn
Anebulo Pharmaceuticals, Inc. Financial Disclosures & SEC Filings - TradingView
Anebulo Pharmaceuticals Inc Income Statement – OTC:ANEB - TradingView
Anebulo Pharmaceuticals Inc Financial Statements – OTC:ANEB - TradingView
Anebulo Pharmaceuticals Inc Statistics – OTC:ANEB - TradingView
Price to earnings ratio of Anebulo Pharmaceuticals Inc – OTC:ANEB - TradingView
Anebulo Pharmaceuticals Inc Earnings and Revenue – OTC:ANEB - TradingView
Basic earnings per share (basic EPS) of Anebulo Pharmaceuticals Inc – OTC:ANEB - TradingView
Anebulo Pharmaceuticals, Inc.(NasdaqCM: ANEB) dropped from S&P TMI Index - marketscreener.com
ANEB Stock Price and Chart — OTC:ANEB - TradingView
Anebulo Pharmaceuticals, Inc. (NASDAQ:ANEB) Short Interest Up 188.7% in February - Defense World
Why retail investors favor Anebulo Pharmaceuticals Inc. stockGap Down & Safe Capital Growth Stock Tips - mfd.ru
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
Anebulo Pharmaceuticals, Inc.(NasdaqCM:ANEB) dropped from Russell Microcap Growth Benchmark Index - marketscreener.com
Anebulo Pharmaceuticals launches self-tender offer to go private - MSN
How sustainable is Anebulo Pharmaceuticals Inc. stock dividend payoutJuly 2025 Weekly Recap & Consistent Profit Alerts - mfd.ru
Dated alert on Anebulo Pharmaceuticals' voluntary delisting from Nasdaq withdrawn - marketscreener.com
Anebulo Pharmaceuticals Reports Second Quarter Fiscal Year 2026 Financial Results and Recent Updates - Business Wire
Anebulo Pharmaceuticals Announces Voluntary Nasdaq Delisting Plan - The Globe and Mail
Anebulo Pharmaceuticals to delist from Nasdaq, deregister with SEC By Investing.com - Investing.com Nigeria
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
Anebulo Pharmaceuticals Announces Intention to Voluntarily Delist from Nasdaq and Deregister with SE - PharmiWeb.com
Anebulo Pharmaceuticals stock plunges after announcing Nasdaq delisting plans By Investing.com - Investing.com Nigeria
Anebulo Pharmaceuticals stock plunges after announcing Nasdaq delisting plans - Investing.com
Anebulo Pharmaceuticals Announced Transfer or Voluntary Withdrawal of Listing - TradingView
Anebulo Pharmaceuticals to delist from Nasdaq, deregister with SEC - Investing.com
Anebulo Pharmaceuticals announces intention to voluntarily delist from Nasdaq and deregister with SEC - marketscreener.com
Anebulo Pharmaceuticals Announces Intention To Voluntarily Delist From Nasdaq And Deregister With SEC - TradingView
Anebulo Pharmaceuticals Announces Intention to Voluntarily Delist from Nasdaq and Deregister with SEC - The Joplin Globe
Anebulo Pharmaceuticals (NASDAQ:ANEB) Trading Down 13.6% – What’s Next? - Defense World
Anebulo Pharmaceuticals (NASDAQ:ANEB) Stock Price Down 13.6% – What’s Next? - Defense World
12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
Anebulo Pharmaceuticals Completes Oversubscribed Share Repurchase Tender - The Globe and Mail
Anebulo Pharmaceuticals Announces Final Results of Tender Offer - TradingView
Investors tender 4.9M Anebulo shares, only 300,000 accepted at $3.50 - Stock Titan
Anebulo Pharmaceuticals Announces Oversubscribed Self-Tender Offer Results - TipRanks
Anebulo completes oversubscribed share repurchase tender offer - Investing.com
Anebulo Pharmaceuticals Announces Preliminary Tender Offer Results - TradingView
Nearly 4.9M shares chase Anebulo’s $3.50 self-tender - Stock Titan
Anebulo completes oversubscribed share repurchase tender offer By Investing.com - Investing.com UK
How Do Investors Really Feel About Anebulo Pharmaceuticals Inc? - Benzinga
Anebulo Pharmaceuticals, Inc. (NASDAQ:ANEB) Short Interest Down 41.3% in December - Defense World
Dip Buying: Can Anebulo Pharmaceuticals Inc stock hit analyst price targetsJuly 2025 Institutional & Community Verified Watchlist Alerts - Bộ Nội Vụ
Meme Stocks: Will Anebulo Pharmaceuticals Inc stock maintain momentum in 2025July 2025 Highlights & Weekly Stock Breakout Alerts - Bộ Nội Vụ
Valuation Update: Can Anebulo Pharmaceuticals Inc withstand a market correctionJuly 2025 Sentiment & Fast Entry High Yield Stock Tips - baoquankhu1.vn
Published on: 2026-01-12 22:22:11 - Улправда
Trading Recap: Will Anebulo Pharmaceuticals Inc stock attract more institutional investorsBuy Signal & Fast Exit Strategy with Risk Control - moha.gov.vn
Will Anebulo Pharmaceuticals Inc. stock deliver shareholder valueQuarterly Portfolio Review & Daily Growth Stock Tips - ulpravda.ru
Will Anebulo Pharmaceuticals Inc. stock attract more institutional investorsCushioning Options Review & lightweight options for faster days - Улправда
Why Anebulo Pharmaceuticals Inc. stock is favored by top institutionsMarket Sentiment Report & Community Consensus Picks - Улправда
Anebulo Pharmaceuticals Inc (ANEB) 財務データ
収益
当期純利益
現金流量
EPS
3.69%
0.68%
大文字化:
|
ボリューム (24 時間):